Leadership Team 2014-2015
President
Zhiyong Yang, Ph.D.
Senior Principal Scientist, Pfizer Inc., Cambridge, MA
Chairman of the Board
Shiwen Lin, Ph.D.
Associate Director, Process & Analytical Technologies, Agenus, Inc. Lexington, MA
President-Elect
Susan Qu, Ph.D. MBA
Quality Intelligence and Strategy Principal Project Manager, Genzyme Corporation, a division of Sanofi, Framingham, MA
Vice President
Qinglin Che, Ph.D.
Senior Scientist, Synta Pharmaceuticals, Inc., Lexington, MA
General Manager of Public Relations
Qingqing Cao, Ph.D.
Sr. Engineer, Becton Dickinson (BD), Bedford, MA
General Manager of Operations
Ellen Fan, MSc.
Sr. Scientist, Arsenal Medical Inc. Watertown, MA
Treasurers
Liping Zhou, Ph.D.
Senior Scientist, Ipsen Biosciences., Cambridge, MA
Zhendong Zhu, Ph.D.
Principal Investigator, Celgene Avilomics Research, Bedford, MA
Legal Counsel
Fred Gilman
Attorney at Law, Lynch, DeSimone & Nylen, LLP, Boston, MA
Executive Committee Members
Lan Cao, Ph.D.
Senior Fellow/Assoiate Director, Cell & Gene Therapy, Process Development at Novartis, Morris Plains, NJ
Yin Chen, Ph.D.
Director of Business Development at Accelagen
Kevin Fang, Ph.D.
Sr. Director of Medicinal Chemistry, Sunovion Pharmaceuticals Inc., Marlborough, MA
Henry Gu, J.D.
Senior IP Counsel, Cubist Pharmaceuticals, Lexington, MA
Jianfeng Jeff Hang, Ph.D.
Regulatory Affairs and Quality System Consultant, Makromed, Inc., Salem, NH
Fred Hu, Ph.D.
Executive Director of Discovery Chemistry Services, ChemPartner, Shanghai, China
Shengfang Jin, Ph.D.
Sr. Director/Biology, Agios Pharmaceuticals, Inc., Cambridge, MA
Jinbo Lee, Ph.D.
Co-founder and CSO, Scilligence Corporation, Burlington, MA
Jo Lee, M.Ec.
Senior Director, Marketing & Business Development, Howfond, Inc.
Howard (Hao) Li, Ph.D.
Associate Director, Program Office, Novartis Institutes of Biomedical Research, Inc., Cambridge, MA
Carrie Liu, Ph.D.
Associate Director of Analytical Chemistry, Concert Pharmaceuticals, Lexington, MA
Sue Ma, M.D.
Scientist II, Novartis Institute of BioMedical Research, Cambridge, MA
Eric Shi, Ph.D.
Investigator, GSK, Waltham, MA
Ji Shi
Equity research associate, Cowen & Company, Boston MA
Shallwei Sun
President and General Manager, Callisyn Biomedical, Inc, North Andover, MA
Ze Tian, Ph.D.
Staff Scientist, Curis Inc., Lexington, MA
Wendy Yang, MBA
Sr. Project Manager, Genzyme Corporation, a division of Sanofi, Waltham, MA
Yikai Wang, Ph.D.
The Broad Institute, Cambridge, MA
Yongzhong Wang, Ph.D.
Deputy General Manager, Kanghong Biotechnology Co. Ltd., Chengdu, China
Yueming Wang, MBA
Deputy General Manager, Tide Pharmaceutical Co. Ltd., Beijing, China
Zhigang Wang, Ph.D.
Sr. Principal Scientist, Celgene Avilomics Research, Bedford, MA
Li Xing, Ph. D.
Senior Principal Scientist, Pfizer Inc. Cambridge, MA
Jingzhong Zhang, Ph.D.
Wei Zhang, Ph.D.
Staff Scientist, Siemens Healthcare Diagnostics, Norwood , MA
Weiyi (Wendy) Zhang, Ph.D.
Senior Director of Business Development, Sundia MediTech Compnay
Youxin Zhang, Ph.D.
Managing Consultant, Navigant Consulting, Boston, MA
Board of Directors
Zhihong Chen, Ph.D.
Past President (2011-2012)
Chaoyang Dai, Ph.D.; Past president (2010-2011)
Vice President of Operations, Acebright, Inc. Bedford, MA
Jun Han, Ph. D.; Founding President
CEO, SOTA International LLC, Boston, MA
Lixin Shen, Ph. D.
President and CEO, Wuxi Howfond Biopharma Co., Ltd., Jiangsu, China
Zhao-Kui Wan, Ph. D.; Past-President (2009-2010)
Head of Chemistry, Jassen Pharmaceutical Companies of Johnson & Johnson, Shanghai, China
Yihan Wang, Ph. D.
President/CEO, TargetRx, Inc., Shenzhen, China
Erxi Wu, Ph. D.
Assistant Prof., North Dakota State University, Fargo, ND
Junjun Wu, Ph. D.; Past President (2007-2009)
CEO，WuXi AllNature Biotech LLC, Jiangsu, China
Philip Zhang, Ph. D., J. D.; Past President (2012-2013)
Co-Founder and Co-Managing Principal, Milstein Zhang & Wu LLC, Newton, MA
Xiang Yang Yu, Ph. D.; Past president (2013-2014)
Program Manager, Accellient Partners LLC, Waltham, MA
CABA Advisors
Youssef Bennani, Ph. D.
Vice President/Discovery Chemistry, Vertex Pharmaceuticals Inc., Cambridge, MA
Tim Clackson, Ph. D.
President of Research and Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc., Cambridge, MA
Yuan-Hua Ding, Ph. D.
Senior Director & Head of External R&D Innovation - Asia, Pfizer
Pierre Dodion, M. D., MBA
Sr. VP, Corporate Development, Ariad Pharmaceuticals Inc., Cambridge, MA
Chen Li, Ph. D.
Chief Executive Officer, Hua Medicine, Inc., Shanghai, China
Luke Li, Ph. D.
Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer
Shi Li, Ph. D.
CEO, Zerun Biotechnology, Shanghai, CHINA
Yuanli Liu, Ph. D.
Director of China Initiative, Sr. Lecturer on International Health, Dept. of Global Health and Population, Harvard School of Public Health
Dawei Ma , Ph. D.
Professor, Shanghai Institute of Organic Chemistry, Shanghai, China
Tarek Mansour, Ph. D.
EVP of Research & Development, Xenon Pharmaceuticals Inc., Vancouver, Canada
Tse Ping
Chairman, Sino Biopharmaceutical Ltd., Beijing, China
John Piwinski, Ph. D.
Principal, JJPiwinski Pharma Consulting, LLC, New York, NY
Steve Projan, Ph. D.
Sr. V.P. R&D, Innovative Medicines Head of Infectious Diseases & Vaccines, MedImmune, Gaithersburg, MD
Tomi Sawyer, Ph. D.
Chief Scientific Officer and Senior Vice-President, Aileron Therapeutics, Cambridge, MA
Liming Shao, Ph. D.
Senior Director/Medicinal Chemistry, Sepracor Inc., Marlborough, MA
Suvit Thaisrivongs, Ph. D.
Vice President, Pfizer, Inc., Cambridge. MA
Roger Tung, Ph. D.
CEO and President, Concert Pharmaceuticals, Lexington, MA
Yibin Xiang, Ph. D.
Senior Director/Medicinal Chemistry, Genzyme Corporation, Cambridge, MA
Gangfeng Xu, Ph. D.
Divisional Vice President, Corporate Licensing & Acquisitions at Abbott Laboratories
Steve Yang, Ph. D.
Head of R&D, Asia & Emerging Markets, AstraZeneca
Howard Yuwen, Ph. D.
Executive Director and Head of North America Regulatory Affairs, Alexion Pharmaceuticals, Inc., Cheshire, CT
